Prevalence of Trichomonas vaginalis and coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in the United States as determined by the aptima Trichomonas vaginalis nucleic acid amplification assay

Journal of Clinical Microbiology

Volumn 50, Issue 8, 2012, Pages 2601-2608

  Ginocchio, C C ^a   Chapin, K ^b   Smith, J S ^c   Aslanzadeh, J ^d   Snook, J ^e   Hill, C S ^e   Gaydos, C A ^f  

^a DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

^c The University of North Carolina at Chapel Hill   (United States)

^d HARTFORD HOSPITAL   (United States)

^e Gen Probe Incorporated   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; APTIMA COMBO 2 ASSAY; APTIMA TRICHOMONAS VAGINALIS NUCLEIC ACID AMPLIFICATION ASSAY; ARTICLE; CAUCASIAN; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; ETHNICITY; FAMILY PLANNING; FEMALE; GEOGRAPHIC DISTRIBUTION; GONORRHEA; HISPANIC; HUMAN; MIXED INFECTION; NEGRO; NEISSERIA GONORRHOEAE; NUCLEIC ACID AMPLIFICATION; PAPANICOLAOU TEST; PREVALENCE; PRIORITY JOURNAL; PRISON; RACE; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; UNITED STATES; URINALYSIS; UTERINE CERVIX CYTOLOGY; VAGINA SMEAR;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; COINFECTION; ETHNIC GROUPS; FEMALE; GONORRHEA; HUMANS; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; NEISSERIA GONORRHOEAE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PREVALENCE; RISK FACTORS; TRICHOMONAS VAGINALIS; TRICHOMONAS VAGINITIS; UNITED STATES; YOUNG ADULT;

AMBYSTOMA TIGRINUM STEBBENSI VIRUS; CHLAMYDIA TRACHOMATIS; NEISSERIA GONORRHOEAE; TRICHOMONAS VAGINALIS;

EID: 84864403724     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00748-12     Document Type: Article

References (35)

1. Allsworth JE, Ratner JA, Peipert JF. 2009. Trichomoniasis and other sexually transmitted infections: results from the 2001-2004 National Health and Nutrition Examination Surveys. Sex. Transm. Dis. 36:738-744.
2. American College of Obstetricians and Gynecologists (ACOG). 2006. ACOG practice bulletin. Clinical management guidelines for obstetrician- gynecologists, no. 72: vaginitis. Obstet. Gynecol. 107:1195-1206.
3. Andrea SB, Chapin KC. 2011. Comparison of Aptima Trichomonas vaginalis transcription-mediated amplification and BD Affirm VPIII for detection of T. vaginalis in symptomatic women: performance parameters and epidemiologic implications. J. Clin. Microbiol. 49:866-869.
4. Briselden AM, Hillier SL. 1994. Evaluation of Affirm VP Microbial Identification Test for Gardnerella vaginalis and Trichomonas vaginalis. J. Clin. Microbiol. 32:148-152.
5. Centers for Disease Control and Prevention (CDC). 2011. CDC Grand Rounds: chlamydia prevention: challenges and strategies for reducing disease burden and sequelae. MMWR Morb. Mortal. Wkly. Rep. 60:370-373.
6. Centers for Disease Control and Prevention (CDC). 2010. CDC fact sheet: trichomoniasis. http://www.cdc.gov/std/trichomonas/STDFact -Trichomoniasis.htm.
7. Cherpes TL, et al. 2006. The associations between pelvic inflammatory disease, Trichomonas vaginalis infection, and positive herpes simplex virus type 2 serology. Sex. Transm. Dis. 33:747-752. (Pubitemid 44832936)
8. Cotch MF, et al. 1997. Trichomonas vaginalis associated with low birth weight and preterm delivery. Sex. Transm. Dis. 24:353-360. (Pubitemid 27306585)
9. Datta SD, et al. 2007. Gonorrhea and chlamydia in the United States among persons 14 to 39 years of age, 1999 to 2002. Ann. Intern. Med. 147:89-96. (Pubitemid 351664612)
10. Freeman AH, et al. 2010. Prevalence and correlates of Trichomonas vaginalis among incarcerated persons assessed using a highly sensitive molecular assay. Sex. Transm. Dis. 37:165-168.
11. Gaydos CA, et al. 2011. Trichomonas vaginalis infection in women who submit self-obtained vaginal samples after internet recruitment. Sex. Transm. Dis. 38:828-832.
12. Goyal M, Hayes K, McGowan KL, Fein JA, Mollen C. 2011. Prevalence of Trichomonas vaginalis infection in symptomatic adolescent females presenting to a pediatric emergency department. Soc. Acad. Emerg. Med. 18:763-766.
13. Hardick A, Hardick J, Wood BJ, Gaydos C. 2006. Comparison between the Gen-Probe transcription-mediated amplification Trichomonas vaginalis research assay and real-time PCR for Trichomonas vaginalis detection using a Roche LightCycler instrument with female self-obtained vaginal swab samples and male urine samples. J. Clin. Microbiol. 44:4197-4199. (Pubitemid 44737270)
14. Hardick J, Yang S, Lin S, Duncan D, Gaydos C. 2003. Use of the Roche LightCycler instrument in a real-time PCR for Trichomonas vaginalis in urine samples from females and males. J. Clin. Microbiol. 41:5619-5622. (Pubitemid 37543256)
15. Helms DJ, et al. 2008. Risk factors for prevalent and incident Trichomonas vaginalis among women attending three sexually transmitted disease clinics. Sex. Transm. Dis. 35:484-488. (Pubitemid 351670550)
16. Hollman D, Coupey SM, Fox AS, Herold BC. 2010. Screening for Trichomonas vaginalis in high-risk adolescent females with a new transcription- mediated nucleic acid amplification test (NAAT): associations with ethnicity, symptoms, and prior and current STIs. J. Pediatr. Adolesc. Gynecol. 23:312-316.
17. Hughes G, et al. 2000. Comparison of risk factors for four sexually transmitted infections: results from a study of attendees at three genitourinary medicine clinics in England. Sex. Transm. Infect. 76:262-267.
18. Huppert JS, et al. 2007. Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of Trichomonas vaginalis in young women. Clin. Infect. Dis. 45:194-198. (Pubitemid 47041010)
19. Joesoef MR, Kahn RH, Weinstock HS. 2006. Sexually transmitted diseases in incarcerated adolescents. Curr. Opin. Infect. Dis. 19:44-48. (Pubitemid 43032439)
20. Kissinger P, et al. 2009. Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding. Sex. Transm. Dis. 36:11-16.
21. Madico G, Quinn TC, Rompalo A, McKee KT, Jr, Gaydos CA. 1998. Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples. J. Clin. Microbiol. 36:3205-3210. (Pubitemid 28476166)
22. McClelland RS, et al. 2007. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J. Infect. Dis. 195:698-702.
23. Miller WC, et al. 2005. The prevalence of trichomoniasis in young adults in the United States. Sex. Transm. Dis. 32:593-598. (Pubitemid 41429179)
24. Munson E, et al. 2008. Impact of Trichomonas vaginalis transcription-mediated amplification-based analyte-specific-reagent testing in a metropolitan setting of high sexually transmitted disease prevalence. J. Clin. Microbiol. 46:3368-3374.
25. Nye MB, Schwebke JR, Body BA. 2009. Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women. Am. J. Obstet. Gynecol. 200:188.e1- 188.e7. doi:10.1016/j.ajog.2008.10.005.
26. Radonjic IV, et al. 2006. Diagnosis of Trichomonas vaginalis infection: the sensitivities and specificities of microscopy, culture and PCR assay. Eur. J. Obstet. Gynecol. Reprod. Biol. 126:116-120.
27. Schwebke JR, Burgess D. 2004. Trichomoniasis. Clin. Microbiol. Rev. 17:794-803. (Pubitemid 39372518)
28. Schwebke JR, et al. 2011. Molecular testing for Trichomonas vaginalis in women; results from a prospective U.S. clinical trial. J. Clin. Microbiol. 49:4106-4111.
29. Sutton M, et al. 2007. The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004. Clin. Infect. Dis. 45:1319-1326. (Pubitemid 351411908)
30. United States Census 2010. 2010. http://2010.census.gov/2010census /data/. Accessed 5 April 2011.
31. Van Der Pol B, et al. 2008. Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J. Infect. Dis. 197: 548-554. (Pubitemid 351321532)
32. Van Der Pol B, Williams JA, Orr DP, Batteiger BE, Fortenberry JD. 2005. Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women. J. Infect. Dis. 192:2039-2044. (Pubitemid 41779199)
33. Van der Pol B. 2007. Trichomonas vaginalis infection: the most prevalent nonviral sexually transmitted infection receives the least public health attention. Clin. Infect. Dis. 44:23-25.
34. Wendel KA, Erbelding EJ, Gaydos CA, Rompalo AM. 2002. Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal trichomoniasis. Clin. Infect. Dis. 35:576-580.
35. Workowski KA, Berman SM, Centers for Disease Control and Prevention. 2010. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recommend. Rep. 59(RR-12):1-110.